Written in Partnership with Amir Bakian
In recent years, there has been a lot of buzz surrounding genetic testing and whole genome sequencing as scientists continue to use these tools to collect the necessary data for medical breakthroughs and individualized healthcare. With so much information to be gathered, EDNA, Inc. offers groundbreaking solutions that empower individuals with their own genetic information. At the heart of their product suite is “DNA Advantage,” a game-changing platform that provides consumers with comprehensive genome sequencing and enables them to leverage the true value of their genetic data.
EDNA’s DNA Advantage is a comprehensive solution comprised of sub-products, among which “Avalon” takes center stage. This cutting-edge technology is not just another genetic testing kit—it’s a state-of-the-art whole genome sequencing platform that offers unprecedented insights into your DNA. Avalon’s ability to fill in over 150 million previously unknown base pairs in the human genome sets it apart.
Unlike traditional genetic testing, which focuses on a fraction of your genetic makeup, whole genome sequencing provides a comprehensive look at your entire genetic code. Avalon is your passport to this comprehensive insight, enabling you to explore the very essence of your being, your unique genetic blueprint.
But why is understanding your genetic code so valuable? Genetic information is an intricate map that can unlock many secrets about your health, ancestry, and potential genetic risks. In contrast to genetic testing, which typically assesses a limited number of predetermined genetic markers, whole genome sequencing casts a wide net, allowing you to explore a vast array of genetic variants.
For instance, over 48,000 genetic variants are classified as “known pathogenic,” which means they are associated with various medical conditions. However, regulatory constraints often restrict consumer reports to include only a tiny fraction of these variants. With its extensive sequencing capabilities, EDNA’s Avalon goes beyond these limitations, giving you access to a treasure trove of information that can profoundly impact your life.
Your DNA holds vital information about your predisposition to certain health conditions. With this knowledge, you can take proactive steps to manage your health effectively. It also helps you uncover your genetic heritage and trace your roots across continents and generations, providing a richer understanding of your ancestry.
Armed with your genetic information, medical professionals can tailor treatments and medications to suit your specific genetic profile, ensuring more effective and efficient healthcare and your data can contribute to critical medical research. EDNA facilitates connections between willing participants and researchers, amplifying the potential for breakthroughs in the field.
But EDNA takes things one step further by making sure your genetic information stays in the right hands — yours. Once tested, your data gets encrypted so no one can read it. By leveraging blockchain technology, EDNA creates a DNA ledger that only you can access, ensuring data privacy and ownership guaranteeing that your genetic data remains your property. If companies need your data or would like to acquire it for research, you have the choice of whether you want to volunteer that information or sell it; after all, it’s your information, so why should anyone else benefit from its sale?
In a world where data is the new currency, EDNA’s DNA Advantage revolutionizes the genetic information landscape. It empowers individuals to unlock the secrets hidden within their DNA while also offering the potential for financial gain and meaningful contributions to medical research. With EDNA, you’re not just a bystander in the genetic revolution; you’re at the forefront, harnessing the power of your genetic code to shape a healthier, more informed future. To learn more, visit www.edna.life.
Advertising disclosure: We may receive compensation for some of the links in our stories. Thank you for supporting LA Weekly and our advertisers.